Trial Profile
Meropenem pharmacokinetics in very low birth weight neonates.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Oct 2013
Price :
$35
*
At a glance
- Drugs Meropenem (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- 17 Mar 2012 Actual end date (Mar 2011) added as reported by European Clinical Trials Database.
- 17 Mar 2012 Actual initiation date (Mar 2010) added as reported by European Clinical Trials Database.
- 17 Mar 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database.